Dr. Mehandar Kumar

Claim this profile

Saint Joseph's Regional Medical Center

Studies Cancer
Studies Bladder Cancer
2 reported clinical trials
4 drugs studied

Area of expertise

1Cancer
Mehandar Kumar has run 2 trials for Cancer. Some of their research focus areas include:
HER2 positive
ER positive
ER negative
2Bladder Cancer
Mehandar Kumar has run 1 trial for Bladder Cancer. Some of their research focus areas include:
Stage IV

Affiliated Hospitals

Image of trial facility.
Saint Joseph's Regional Medical Center

Clinical Trials Mehandar Kumar is currently running

Image of trial facility.

T-DM1 + Tucatinib

for Breast Cancer

This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria

More about Mehandar Kumar

Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Mehandar Kumar has experience with
  • Avelumab
  • Cabozantinib S-malate
  • Trastuzumab Emtansine
  • Tucatinib
Breakdown of trials Mehandar Kumar has run
Cancer
Bladder Cancer
Transitional Cell Carcinoma
Urethral Tumors
Ureteral Tumors

Other Doctors you might be interested in

Alissa KahnSaint Joseph's Regional Medical Center

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mehandar Kumar specialize in?
Mehandar Kumar focuses on Cancer and Bladder Cancer. In particular, much of their work with Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Mehandar Kumar currently recruiting for clinical trials?
Yes, Mehandar Kumar is currently recruiting for 1 clinical trial in Paterson New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Mehandar Kumar has studied deeply?
Yes, Mehandar Kumar has studied treatments such as Avelumab, Cabozantinib S-malate, Trastuzumab Emtansine.
What is the best way to schedule an appointment with Mehandar Kumar?
Apply for one of the trials that Mehandar Kumar is conducting.
What is the office address of Mehandar Kumar?
The office of Mehandar Kumar is located at: Saint Joseph's Regional Medical Center, Paterson, New Jersey 07503 United States. This is the address for their practice at the Saint Joseph's Regional Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top